Gene · 8817
Papers1,397
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,397
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WYC-209 suppresses gastric cancer by down-regulating FGF18 via inactivating the STAT3 signaling pathway. | Eur J Pharmacol | 2024 | 39214271 | PubTator, text mining | PubMed |
| RNAseq of Gingival Fibroblasts Exposed to PRF Membrane Lysates and PRF Serum. | Cells | 2024 | 39120336 | PubTator, text mining | PubMed |
| BUB1 potentiates gastric cancer proliferation and metastasis by activating TRAF6/NF-κB/FGF18 through m6A modification. | Life Sci | 2024 | 39025206 | PubTator, text mining | PubMed |
| A systematic approach introduced some immune system targets in rectal cancer by considering cell-free DNA methylation in response to radiochemotherapy. | Cytokine | 2024 | 38906038 | PubTator, text mining | PubMed |
| Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family. | Mil Med Res | 2024 | 38902808 | PubTator, text mining | PubMed |
| Is detection of disease-modifying osteoarthritis drug treatment more effective when performing cartilage morphometry without blinding to MR image acquisition order? | Osteoarthritis Cartilage | 2024 | 38844160 | PubTator, text mining | PubMed |
| Interplay of clinical biomarkers in allergic asthma diagnosis and severity: A case-control study. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38814233 | PubTator, text mining | PubMed |
| Single Injection AAV2-FGF18 Gene Therapy Reduces Cartilage Loss and Subchondral Bone Damage in a Mechanically Induced Model of Osteoarthritis. | Curr Gene Ther | 2024 | 38783531 | PubTator, text mining | PubMed |
| Hydrogel-exosome system in tissue engineering: A promising therapeutic strategy. | Bioact Mater | 2024 | 38699243 | PubTator, text mining | PubMed |
| A comparative study of multiple biomarkers levels in complicated versus noncomplicated type 2 diabetic patients. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38678628 | PubTator, text mining | PubMed |
| Prognostic gene biomarkers for c-Src inhibitor Si162 sensitivity in melanoma cells. | Turk J Biol | 2024 | 38665777 | PubTator, text mining | PubMed |
| A Bionic Thermosensitive Sustainable Delivery System for Reversing the Progression of Osteoarthritis by Remodeling the Joint Homeostasis. | Adv Healthc Mater | 2024 | 38394066 | PubTator, text mining | PubMed |
| Targeted mutagenesis in mice via an engineered AsCas12f1 system. | Cell Mol Life Sci | 2024 | 38280977 | PubTator, text mining | PubMed |
| Effect and mechanism of recombinant human fibroblast growth factor 18 on osteoporosis in OVX mice. | Climacteric | 2024 | 38275172 | PubTator, text mining | PubMed |
| The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression. | Cancer Cell Int | 2024 | 38273381 | PubTator, text mining | PubMed |
| Injectable Microgels with Hybrid Exosomes of Chondrocyte-Targeted FGF18 Gene-Editing and Self-Renewable Lubrication for Osteoarthritis Therapy. | Adv Mater | 2024 | 38266145 | PubTator, text mining | PubMed |
| Fibroblast growth factor signalling regulates the development of tooth root. | J Anat | 2024 | 38258312 | PubTator, text mining | PubMed |
| Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers. | Int J Mol Sci | 2024 | 38255923 | PubTator, text mining | PubMed |
| Adult Animal Stem Cell-Derived Organoids in Biomedical Research and the One Health Paradigm. | Int J Mol Sci | 2024 | 38255775 | PubTator, text mining | PubMed |
| Transcriptomic profiling reveals key early response genes during GDF6-mediated differentiation of human adipose-derived stem cells to nucleus pulposus cells. | JOR Spine | 2024 | 38249721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8817/papers?page=4